APGE
Price
$37.29
Change
-$0.52 (-1.38%)
Updated
May 9 closing price
Capitalization
2.18B
8 days until earnings call
TELO
Price
$2.49
Change
-$0.03 (-1.19%)
Updated
May 9 closing price
Capitalization
74.11M
17 days until earnings call
Ad is loading...

APGE vs TELO

Header iconAPGE vs TELO Comparison
Open Charts APGE vs TELOBanner chart's image
Apogee Therapeutics
Price$37.29
Change-$0.52 (-1.38%)
Volume$848.27K
Capitalization2.18B
Telomir Pharmaceuticals
Price$2.49
Change-$0.03 (-1.19%)
Volume$105.44K
Capitalization74.11M
APGE vs TELO Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APGE vs. TELO commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and TELO is a Hold.

Ad is loading...
COMPARISON
Comparison
May 11, 2025
Stock price -- (APGE: $37.29 vs. TELO: $2.49)
Brand notoriety: APGE and TELO are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 118% vs. TELO: 61%
Market capitalization -- APGE: $2.18B vs. TELO: $74.11M
APGE [@Biotechnology] is valued at $2.18B. TELO’s [@Biotechnology] market capitalization is $74.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $296.96B to $0. The average market capitalization across the [@Biotechnology] industry is $2.18B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileTELO’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • TELO’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than TELO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 8 TA indicator(s) are bullish while TELO’s TA Score has 4 bullish TA indicator(s).

  • APGE’s TA Score: 8 bullish, 2 bearish.
  • TELO’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, APGE is a better buy in the short-term than TELO.

Price Growth

APGE (@Biotechnology) experienced а -7.05% price change this week, while TELO (@Biotechnology) price change was -3.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.24%. For the same industry, the average monthly price growth was +9.39%, and the average quarterly price growth was -13.47%.

Reported Earning Dates

APGE is expected to report earnings on May 19, 2025.

TELO is expected to report earnings on May 28, 2025.

Industries' Descriptions

@Biotechnology (-6.24% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($2.18B) has a higher market cap than TELO($74.1M). APGE YTD gains are higher at: -17.682 vs. TELO (-39.563). TELO has higher annual earnings (EBITDA): -12.19M vs. APGE (-216.68M). APGE has more cash in the bank: 521M vs. TELO (1.27M). APGE (0) and TELO (0) have equivalent revenues.
APGETELOAPGE / TELO
Capitalization2.18B74.1M2,938%
EBITDA-216.68M-12.19M1,777%
Gain YTD-17.682-39.56345%
P/E RatioN/AN/A-
Revenue00-
Total Cash521M1.27M41,153%
Total Debt11.8MN/A-
TECHNICAL ANALYSIS
Technical Analysis
APGETELO
RSI
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
72%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 19 days ago
78%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TELO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NYVBX18.710.01
+0.05%
Davis NY Venture B
CLPCX11.42N/A
N/A
Catalyst Nasdaq-100 Hedged Equity C
IYBIX23.41N/A
N/A
Macquarie Balanced Fund Class I
ETLCX13.66-0.03
-0.22%
Eventide Large Cap Focus C
PSGIX19.59-0.10
-0.51%
BlackRock Advantage Small Cap Gr Instl

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 53% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-1.38%
SYRE - APGE
53%
Loosely correlated
+9.64%
ATXS - APGE
52%
Loosely correlated
-3.86%
ELVN - APGE
52%
Loosely correlated
-1.13%
ERAS - APGE
50%
Loosely correlated
N/A
KRYS - APGE
50%
Loosely correlated
-3.64%
More

TELO and

Correlation & Price change

A.I.dvisor tells us that TELO and ATXS have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that TELO and ATXS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TELO
1D Price
Change %
TELO100%
-1.19%
ATXS - TELO
31%
Poorly correlated
-3.86%
APGE - TELO
29%
Poorly correlated
-1.38%
ENGN - TELO
29%
Poorly correlated
-12.68%
ALZN - TELO
29%
Poorly correlated
+21.87%
DNLI - TELO
27%
Poorly correlated
-0.42%
More